The Latest: Canada OKs vaccine change between 1st, 2nd dose


In this Saturday, April 10, 2021 photo, a syringe is loaded with the Pfizer-BioNTech COVID-19 vaccine at a clinic in Richmond, British Columbia, Canada. On Wednesday, May 5, 2021, Canada’s health regulator authorized the Pfizer vaccine for ages 12 and older. (Jonathan Hayward/The Canadian Press via AP)

TORONTO — Canada’s National Advisory Committee on Immunization says people who got the Oxford-AstraZeneca vaccine for the first dose can be offered either Pfizer-BioNTech or Moderna for the second.

The advice affects more than two million Canadians who received the Oxford-AstraZeneca vaccine before provinces stopped using it for first doses last month. The vaccine is potentially linked to a rare but serious blood clotting syndrome. In Canada, 41 confirmed or suspected cases of vaccine-induced thrombotic thrombocytopenia have been diagnosed and five people have died.

Several European countries are giving Pfizer or Moderna as second doses to AstraZeneca recipients, including Denmark, Finland, France, Germany, Sweden, Norway and Spain.

NACI’s published report says AstraZeneca recipients can be offered the same vaccine if they want it, or can be given either Pfizer or Moderna. They say they are basing their advice on the risk of VITT, and emerging evidence that mixing and matching different types of vaccines is not only safe but may produce a better immune response.

The guidance is not binding but most provincial governments have indicated they were waiting for the information before setting their policies for second doses.

___

MORE ON THE VIRUS OUTBREAK:

— Peru raises COVID-19 death toll sharply, up to over 180,000 from previous count of nearly 70,000

— Son’s grief, guilt become tribute honoring COVID-19 victims

— Japan’s vaccine push ahead of Olympics looks to be too late

— Businesses close in Malaysia's second lockdown as surge puts health care system on verge of collapse

___

— Follow more of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine


___

HERE’S WHAT ELSE IS HAPPENING:

NEW YORK — Health researchers estimate that during the early months of the U.S. COVID-19 epidemic, 7,000 to 10,000 more kidney disease patients died than normally would.

The Centers for Disease Control and Prevention published the report Tuesday.

The researchers focused on about 800,000 patients who early last year had kidney failure. About 60,000 of them died between the beginning of February and the end of August last year.

The researchers compared those numbers to trends in the same patient population during other recent years, and concluded such deaths had risen by as much as 10,000. Patterns of where the patients died were similar to maps of where COVID-19 hit the United States in the first months of the pandemic. But the authors say more research is needed to determine what drove the increase – whether it was due to coronavirus infections, difficulty accessing medical care or other reasons.

Overall, between Feb. 1, 2020 and May 15, 2021, the CDC reports that the nation saw about 643,000 more deaths than usual.

___

WASHINGTON — The Memorial Day weekend has produced the two busiest days for U.S. air travel since early March 2020.

The U.S. Transportation Security Administration said about 1.96 million people passed through U.S. airport security checkpoints on Friday, and 1.90 million did so on Monday. Tuesday was also expected to be busy, as travelers returned home after the Memorial Day weekend.

Analysts expect travel to continue rising slowly now that many Americans are vaccinated against COVID-19 and airlines are adding more flights.

In May, an average of 1.6 million people a day were screened at U.S. airports, down one-third from the 2.4 million people a day who went through TSA checkpoints in May 2019.

___

LONDON — London’s Heathrow Airport has reopened a terminal that was mothballed during the coronavirus pandemic to handle passengers now arriving from high-risk countries. Critics say the action should have been taken sooner.

Britain has barred travelers from a “red list” of 43 coronavirus hotspots including India, Brazil and Turkey. U.K. nationals and residents returning from those countries face a mandatory 10-day quarantine in a hotel. Other travelers coming from “amber list” countries like the United States can do their mandatory 10-day quarantine at home in the U.K.

Critics have complained that red list passengers have been using the same massive airport arrivals hall as travelers from other destinations, though in separate lines, since the hotel quarantines were introduced in February.

Starting Tuesday, red list arrivals will pass through the airport’s Terminal 3, which was closed in April 2020 as international air travel plummeted.

____

CAMBRIDGE, Mass. — American pharmaceutical company Moderna says it has begun the process to win full U.S. regulatory approval for the use of its COVID-19 vaccine in adults.

Moderna announced it has begun a “rolling submission” to the Food and Drug Administration of data from its studies of the two-dose vaccine.

Moderna’s vaccine already has been cleared for emergency use by the FDA and regulators in numerous other countries. So far, more than 124 million doses have been administered in the United States.

Large-scale studies of the shots continued after Moderna’s emergency authorization. The FDA will scrutinize the information to see if the vaccine meets stringent criteria for full licensure.

Moderna is the second COVID-19 vaccine maker to seek full approval, following Pfizer and German partner BioNTech.

Last week, Moderna also announced that its vaccine appears safe and effective in kids as young as 12. The company plans to seek emergency authorization for teen use this month.

____

GENEVA — The World Health Organization has issued an emergency use listing for the COVID-19 vaccine made by Sinovac in adults aged 18 and over, the second such authorization it has granted to a Chinese company.

The U.N. health agency said on Tuesday that data submitted to its experts showed that two doses of the vaccine prevented people from getting symptoms of COVID-19 in about half of those who got the vaccine. WHO said there were few older adults enrolled in the research, so it could not estimate how effective the vaccine was in people over age 60.

WHO’s authorization means the vaccine can be bought by donors and other U.N. agencies for use in poorer countries, including in the U.N.-backed initiative to distribute COVID-19 vaccines globally known as COVAX.

Last month, WHO gave the green light to the COVID-19 vaccine made by Sinopharm. It has also licensed vaccines developed by Pfizer-BioNTech, Johnson & Johnson, Moderna Inc and AstraZeneca.

The COVAX effort has been slowed considerably after its biggest supplier in India said it would not be able to provide any more vaccines until the end of the year.

To date, there is no confirmed deal for Sinovac doses with COVAX.

____

ALGIERS, Algeria — Algeria partially reopened its skies to flights after a 14-month shutdown to try to keep out the coronavirus.

A first flight of the national carrier Air Algerie took off for Paris on Tuesday and another was expected to land in Algiers, the capital.

Great caution governed the reopening, with limited flights, tests for COVID-19 and a required quarantine. Those heading to Algiers must have a negative test less than 36 hours before boarding, and all passengers must undergo a five-day quarantine in a hotel requisitioned by the state.

A negative test result is required to leave the hotel.

____

LONDON — Britain’s government said no new coronavirus deaths were reported Tuesday, the first time this has happened since July 2020.

The positive news came amid concern about increasing cases in the U.K. of the coronavirus variant first identified in India, and uncertainty about whether authorities will press ahead with the final stages of easing social restrictions later this month.

As of Tuesday there have been a further 3,165 confirmed COVID-19 cases in the U.K., compared to about 2,500 cases last week. Some parts of northwestern England have seen a steep rise in infections. Officials have said that up to three-quarters of these new cases are the Indian variant, which they say appear to be more transmissible.

Official figures showed no deaths within 28 days of testing positive for the coronavirus were reported Tuesday. The U.K. total death toll stood at 127,782, the highest in Europe.

____

GENEVA — The European Medicines Agency said it has recommended approving two additional manufacturing and finishing sites for the coronavirus vaccine made by Pfizer and BioNTech.

The EU drug regulator said in a statement on Tuesday that the additional vaccine production and filling sites were at Pfizer’s factory in Puurs, Belgium. The EMA said its decision, based on a review of manufacturing data submitted by BioNTech, is expected to have “a significant and immediate impact” on the supply of the vaccine for the 27 countries in the EU made by Pfizer and BioNTech.

Last month, the EU Commission signed a third contract with Pfizer-BioNTech to obtain an additional 1.8 billion doses of their vaccine from 2021 to 2023. That contract stipulated that vaccine production be based in the EU and that delivery to the EU be guaranteed in 2022. In April, the EU sued AstraZeneca for its failure to deliver on the hundreds of millions of doses Europe had been promised in its contract.

____

NEW YORK — A play about young Black men trapped on a street corner has positioned itself as the first Broadway show audiences can watch live when the Great White Way restarts.

Antoinette Chinonye Nwandu’s “Pass Over” will begin performances Aug. 4 at the August Wilson Theatre, several weeks before any other show.

Riffing of “Waiting for Godot,” the play is seemingly perfect for a post-COVID-19 Broadway: Just three actors and an intermission-less 85-minute running time.

The play was first staged in 2017 in Chicago and was filmed by Spike Lee. It was most recently produced at Lincoln Center’s off-Broadway theater in 2018 and that cast will make the leap to Broadway.

____

ISLAMABAD — Pakistani authorities on Tuesday launched a locally processed, filled and packaged Chinese CanSino vaccine by giving it the name of PakVac.

The development comes weeks after China supplied the vaccine in bulk in concentrated form for filling and packaging in Pakistan.

The Chinese concentrate is being processed, sterilized and packed at a health facility in the capital, Islamabad, with a capacity of rolling out three million doses a month.

In a speech at a ceremony, Pakistan’s minister for planning and development, Asad Umar, thanked China for helping Pakistan to locally process, fill and package the vaccine.

The launch comes amid a decline in fatalities and infections from the coronavirus.

Pakistan has registered 20,850 deaths among 922,824 confirmed COVID-19 cases since last year.

____

LANSING, Mich. — Michigan crossed a threshold in the COVID-19 pandemic on Tuesday with a lifting of certain restrictions at outdoor events and inside bars and restaurants.

Masks no longer are required outdoors, and capacity limits are extinguished at outdoor sports events and concerts.

Restaurants and bars can operate indoors at 50% capacity and can stay open past 11 p.m. There’s no limit on the number of people at one table. Full capacity returns on July 1.

Gov. Gretchen Whitmer announced the changes on May 20 as new coronavirus cases were slowing down and more Michigan residents were getting vaccinated against COVID-19.

There were only 445 new cases reported Saturday, the latest figures available because of the Memorial Day holiday.

____

ROME — Italians may eat and drink indoors at bars and restaurants for the first time in months, and that includes the morning ritual of having an espresso or cappuccino at a local cafe.

Until Tuesday, businesses had to either offer outdoor seating, or serve coffee in takeaway cups, admonishing customers to step away from the bar before sipping or run afoul of virus restrictions.

Rome resident Paolo Leoni enjoyed an espresso at the Toraldo Cafe in the center of Rome. He said that “one coffee gives us the feeling of living serenely again.”

Cafe owner Alessandro Rappini says that seeing the place fill up again after four months “gives me a huge sense of satisfaction.”

Italy began rolling back pandemic restrictions in April as the number of new cases showed signs of steady decline. To date, nearly 35 million people in the country of 60 million residents have received at least one shot of a COVID-19 vaccine.

___

BERLIN — German authorities are investigating allegations of fraud involving the massive rollout of free coronavirus tests, which are being carried out now in converted cellphone stores, beauticians and art galleries across the country.

Germans have to present a negative test result in order to enter non-essential stores, visit restaurants or bars, or attend small-scale cultural events. The government pays for one free test per person each week, which has led to a proliferation of more than 15,000 businesses offering antigen tests that provide results within 20 minutes.

“There is the suspicion, a very well-founded suspicion after everything I’ve seen, that there’s also been fraud,” Jens Spahn, the country’s health minister, said Tuesday.

The issue has once again raised questions of who is accounting for the German government’s spending splurge in response to the pandemic.

Last year, numerous applicants seeking government support for businesses affected by the lockdown were found to have made fraudulent claims, leading to a tightening of rules and severe delays in payments as further checks were conducted.

____

Should you invest $1,000 in Moderna right now?

Before you consider Moderna, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moderna wasn't on the list.

While Moderna currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Pfizer (PFE)
4.9942 of 5 stars
$26.32+0.2%6.38%73.11Hold$36.33
Johnson & Johnson (JNJ)
4.9005 of 5 stars
$149.56+0.3%3.18%9.32Hold$175.86
Moderna (MRNA)
3.9826 of 5 stars
$107.89+3.3%N/A-8.69Hold$126.49
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: